# PYLARIFY

NDC: 71258-022
Generic name: PIFLUFOLASTAT F-18
Labeler / Manufacturer: Progenics Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20210526

FDA application: NDA214793

## Active ingredients

- PIFLUFOLASTAT F-18: 80 mCi/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71258-022"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71258-022
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a00e5cbc-4fd5-4280-82ec-cd3498df4553